APOE and Alzheimer disease: This finding is compelling, as metabolic changes are thought to be a core component of neurodegenerative and neurodevelopmental disorders [110,111] and APOE, a key genetic risk factor for AD, plays a central role in lipid metabolism and transport [112,113].